Norsulfazol Kupro (Sulfathiazole)

Sulfathiazole, the active ingredient in Norsulfazol Kupro, is a sulfonamide presented as a topical formulation for topical use. It treats bacterial skin infections in patients requiring local antimicrobial therapy.

GNH USA supplies Norsulfazol Kupro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norsulfazol Kupro is a sulfonamide antibacterial applied to the skin to manage bacterial infections.

- Impetigo: reduces bacterial load and promotes healing of superficial skin lesions. - Cellulitis: helps control infection and limits spread of inflammation in deeper skin layers. - Folliculitis: alleviates bacterial colonisation of hair follicles and reduces associated redness and pus formation.

Topical application of sulfathiazole may cause local reactions and, rarely, systemic hypersensitivity.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Itching: localized pruritus following use. - Burning sensation: transient heat feeling on the skin. - Dryness: temporary loss of moisture. - Rash: mild erythematous eruption. - Peeling: superficial desquamation.

Serious or Rare Side Effects: - Allergic dermatitis: severe skin reaction with swelling and vesicles. - Stevens‑Johnson syndrome: rare, life‑threatening mucocutaneous disorder. - Toxic epidermal necrolysis: extensive skin detachment. - Systemic hypersensitivity: fever, malaise, and organ involvement. - Hemolysis in G6PD deficiency: breakdown of red blood cells. - Anaphylaxis: acute, potentially fatal allergic response.

Before using Norsulfazol Kupro, consider the following safety measures. - Assess allergy history: avoid in patients with known sulfonamide hypersensitivity. - Evaluate skin integrity: do not apply to extensive open wounds or burns. - Monitor for systemic reactions: discontinue if signs of severe allergy appear. - Use with caution in G6PD deficiency: risk of hemolysis. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sulfathiazole may interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Oral sulfonamide antibiotics: increased risk of systemic hypersensitivity. - Methotrexate: additive folate antagonism may enhance toxicity.

Moderate Interactions (Monitor Closely): - Phenobarbital: may increase hepatic metabolism of sulfonamides. - Oral contraceptives: potential reduction in efficacy. - Warfarin: possible enhancement of anticoagulant effect, monitor INR.